Tuesday, November 27, 2012

Investopedia: Will Bad Leads Lead St. Jude Astray?

For a company that sold Wall Street on a pretty aggressive set of expectations, St. Jude Medical (NYSE:STJ) is certainly seeing the other side of the momentum trade. Worries about the company's pipeline and competitive positioning would be bad enough in their own right, but ongoing worries about the company's high-voltage leads threaten not only the company's valuation but also its competitive standing.

Please click here for more:

No comments: